SUN PHARMACEUTICAL INDUSTRIES H-1B Visa Sponsorship & Salary Data

The median H-1B salary at SUN PHARMACEUTICAL INDUSTRIES is $105,536, based on 63 certified filings from FY 2020 to FY 2026. This is 12% lower than the national H-1B median salary of $120,000. Compensation at SUN PHARMACEUTICAL INDUSTRIES reflects their market positioning, with entry-level roles starting around $85,423 and senior positions reaching $195,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at SUN PHARMACEUTICAL INDUSTRIES range from $76,112 at the 10th percentile to $195,000 at the 90th percentile, showing a $118,888 spread across experience levels and roles. The 25th percentile is $85,423 and the 75th percentile is $139,276.

Yes, SUN PHARMACEUTICAL INDUSTRIES actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 67 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 63 certified applications and a 1.5% denial rate, SUN PHARMACEUTICAL INDUSTRIES maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), SUN PHARMACEUTICAL INDUSTRIES filed 3 H-1B applications, with 2 certified and 0 denied. Over 7 years of data, SUN PHARMACEUTICAL INDUSTRIES has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

SUN PHARMACEUTICAL INDUSTRIES's LCA (Labor Condition Application) denial rate is 1.5%, with 1 out of 67 applications denied across all years. This translates to a 98.5% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating SUN PHARMACEUTICAL INDUSTRIES as a potential H-1B sponsor.

This is a good approval rate, comparable to industry averages. SUN PHARMACEUTICAL INDUSTRIES demonstrates reliable H-1B sponsorship practices.

SUN PHARMACEUTICAL INDUSTRIES sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 63 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles SUN PHARMACEUTICAL INDUSTRIES most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at SUN PHARMACEUTICAL INDUSTRIES:

The most frequently sponsored role is Senior Associate, Regulatory Affairs with 4 filings at a median salary of $97,004. This is followed by Supply Chain Analyst (3 filings) and Sr. Manager, Incentive Compensation, Analytics And Reporting.

SUN PHARMACEUTICAL INDUSTRIES's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where SUN PHARMACEUTICAL INDUSTRIES sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top SUN PHARMACEUTICAL INDUSTRIES H-1B locations:

The largest H-1B hub for SUN PHARMACEUTICAL INDUSTRIES is Princeton, NJ with 34 filings at a median salary of $125,000. The highest-paying location is Lexington, MA at $136,809 median. Salaries range from $89,768 to $136,809 across office locations.

SUN PHARMACEUTICAL INDUSTRIES's median H-1B salary has increased by +67% from FY 2020 ($83,890) to FY 2026 ($140,000). Tracking salary trends over time reveals how SUN PHARMACEUTICAL INDUSTRIES adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at SUN PHARMACEUTICAL INDUSTRIES.

Year-by-year breakdown:

• FY 2022: $136,500 (12 certified)
• FY 2023: $110,000 (5 certified)
• FY 2024: $134,940 (10 certified)
• FY 2025: $108,678 (14 certified)
• FY 2026: $140,000 (2 certified)

This 67% growth reflects strong compensation adjustments at SUN PHARMACEUTICAL INDUSTRIES, keeping pace with market demands for H-1B talent.

SUN PHARMACEUTICAL INDUSTRIES primarily files H-1B applications at Wage Level III, accounting for 34% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making SUN PHARMACEUTICAL INDUSTRIES's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 82% of positions at Level II or higher, SUN PHARMACEUTICAL INDUSTRIES typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

SUN PHARMACEUTICAL INDUSTRIES's median H-1B salary of $105,536 is 12% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating SUN PHARMACEUTICAL INDUSTRIES's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare SUN PHARMACEUTICAL INDUSTRIES's offerings with similar companies in your field for a more accurate assessment.

SUN PHARMACEUTICAL INDUSTRIES's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. SUN PHARMACEUTICAL INDUSTRIES's higher proportion of Level III-IV positions (68%) may benefit from wage-based lottery prioritization.

With 63 certified filings, SUN PHARMACEUTICAL INDUSTRIES invests significantly in H-1B sponsorship. The company's 1.5% denial rate suggests solid H-1B processing practices.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.